PPA Category III status for safety in nasal decongestants tentatively decided -- FDA.
This article was originally published in The Tan Sheet
Executive Summary
PPA TO BE DESIGNATED CATEGORY III FOR SAFETY IN OTC NASAL DECONGESTANT and weight control products in upcoming proposed rules while additional safety data on the ingredient are being collected, FDA said in a May 17 letter to Caprice-Greystoke. The agency explained that its position on phenylpropanolamine hydrochloride (PPA)'s status in the pending proposed rules is "tentative." The letter responds to the company's third citizen petition on PPA, dated Dec. 8, 1995.